These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preface. A new era in dialysis reimbursement. Kotanko P; Levin NW; Ronco C Blood Purif; 2011; 31(1-3):59-60. PubMed ID: 21228567 [No Abstract] [Full Text] [Related]
4. CKD: it does not have to be the harbinger of cardiac doom. Baum SJ Nephrol News Issues; 2008 Oct; 22(11):32, 34, 36. PubMed ID: 19009858 [No Abstract] [Full Text] [Related]
5. Cinacalcet and cardiovascular mortality in hemodialysis patients. Klein GL Kidney Int; 2010 Oct; 78(8):820. PubMed ID: 20877380 [No Abstract] [Full Text] [Related]
8. Risk factors for cardiovascular disease in children on chronic hemodialysis - Uremia related (non-traditional) risk factors, part II. Šulović LS Vojnosanit Pregl; 2017 Jan; 74(1):54-8. PubMed ID: 29350892 [No Abstract] [Full Text] [Related]
10. Kidney disease and cardiovascular risk. Tonelli M; Pfeffer MA Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079 [TBL] [Abstract][Full Text] [Related]
11. Cystatin C as a predictor for outcomes in patients with negligible renal function. Ho LC; Sung JM; Tsai YS; Wang HH; Li YC; Chen YT; Chang MY; Hung SY Blood Purif; 2014; 38(2):81-8. PubMed ID: 25342167 [TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease in children and adolescents. Massengill SF; Ferris M Pediatr Rev; 2014 Jan; 35(1):16-29. PubMed ID: 24385562 [No Abstract] [Full Text] [Related]
15. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial. Iseki K; Arima H; Kohagura K; Komiya I; Ueda S; Tokuyama K; Shiohira Y; Uehara H; Toma S; Nephrol Dial Transplant; 2013 Jun; 28(6):1579-89. PubMed ID: 23355629 [TBL] [Abstract][Full Text] [Related]
16. SHARP: a stab in the right direction in chronic kidney disease. Stevens KK; Jardine AG Lancet; 2011 Jun; 377(9784):2153-4. PubMed ID: 21663950 [No Abstract] [Full Text] [Related]
17. Cardiovascular Disease Risk in Children With Kidney Disease. Sethna CB; Merchant K; Reyes A Semin Nephrol; 2018 May; 38(3):298-313. PubMed ID: 29753405 [TBL] [Abstract][Full Text] [Related]
18. Kidney care and renal disease. Casey G Nurs N Z; 2012 May; 18(4):20-4. PubMed ID: 22866466 [No Abstract] [Full Text] [Related]
19. Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms. Cozzolino M; Biondi ML; Galassi A; Cusi D; Brancaccio D; Gallieni M Blood Purif; 2010; 29(4):347-51. PubMed ID: 20357434 [TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response. Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]